Print

Test Predicts Novartis AG's Kinase Inhibitor Resistance in CML, Hokkaido University Study  
7/29/2010 7:03:42 AM

MedPage Today -- A novel laboratory test may accurately distinguish which chronic myeloid leukemia (CML) patients will develop resistance to imatinib (Gleevec), researchers said.
//-->